Measurement of circulating thyroxine concentration is currently favoured as the first-line test of thyroid function. Almost without exception in the UK this is performed by a radioimmunoassay (RIA) procedure, usually sermautomated. . Galen et al. l established a satisfactory optical Immunoassay for the routine screening of patients for serum thyroxine. Their method, a homogeneous enzyme immunoassay (EIA), was designed for an automatic multichannel analyser, the AutoChemist (LKB, Sweden), performing the thyroxine analysis as part of a 23-test biochemical profile. With the introduction of medium-priced fast centrifugal analysers (CFA) EIA of thyroxine becomes a viable alternative to RIA, and a trial was undertaken to compare the so-called 'enzyme multiplied immunoassay technique' (EMIT) performed on a centrifugal analyser with a conventional RIA procedure.
Material and methods

STANDARDS
Standard thyroxine (T4) solution in serum was prepared as previously described."
Standards for the Syva (Maidenhead, Berks) EMIT kit were reconsitituted as per instructions.
EMIT
Techniques for manual, semiautomated and centrifugal analyser T4 methods are availabie with the kit reagents. Working reagents for use with the Cobas Bio CFA are required as follows:
1 Serum T4 releasing reagent. Sodium hydroxide O·5 mol/l containing a small amount of Liplex (Syva, Maidenhead, Berks);
2 Antiserum-buffer substrate. To 1 vol each of antibody reagent and glycine solution (1 mol/I) add 5·5 vol buffer substrate, pH 9· 5. Sufficient for two rotor discs may be prepared;
5· 5 vol buffer substrate immediately before each machine run. Sufficient for one rotor disc only (30 cuvettes) is prepared.
The method requires 60 !Jol serum samples in the Cobas Bio sample cups. The serum samples, controls, and standards are set up in the first sample disc, mixed with 60 !Jol T4-releasing reagent, and allowed to stand for 20-50 minutes at room temperature before assay. This gives adequate time for the preparation of reagents.
With the first sample disc in position, 16!Jol each of pretreated sample, 10 !Jol water wash, and 75 !Jol antiserum-buffer substrate are automatically loaded into the rotor disc, spun for 10 seconds to mix, and transferred to the cuvettes.
Next, additions of 65 !Jol enzyme-T4 reagent and 20 !Jol water wash are automatically loaded, and a second spin transfers them to the cuvettes and mixes. After a lag phase, absorbance is monitored every 20 seconds between 2 and 9 minutes followed by printout of decrease in absorbance per minute during the linear phase. While absorbances are being printed, a second sample disc is set up with serum and control samples only. Sufficient additional enzyme-T4-buffer substrate is freshly prepared, and the analysis sequence is restarted. Absorbance changes for the standards are used to produce a graphic (log-linear) or computer-generated plot from which the sample T4 values are derived. RIA The Tetra Tab RIA kit method (distributor: General Diagnostics, Eastleigh) has previously been shown to give good performance. 3 Thyroxine is released from serum with Hel (25 mmol/I), mixed with labelled T4, and incubated with T4-antibody. After ammonium sulphate precipitation of antibody-bound T4, unbound labelled T4 is measured in a gamma counter. Per cent bound counts are plotted against log T4 concentration; alternatively, a spline-fit polynomial allows sample and control T4 values to be derived with a small computer such as the Wang 2000, The technique is that of the kit manufacturer, Nuclear Medical Laboratories Inc, USA (NML).
Results
STANDARDISATION
3 Enzyme-T4-b~ffer substrate. To each volume of Sixty-six serum samples were analysed for T4 using enzyme-T4 conjugate reagent containing NAD+ add both NML method and the primary, standardised, 159
Comparison of serum thyroxine concentrations measured by EMIT-CFA procedure (EIA) and previously established method (RIA); 45°line is shown.
in-house, RIA method. The correlation coefficient was 0·941 and the slope of regression line 1·04. When analysed by EIA, the NML (TetraTab) standards appeared to give results slightly high by 5-12%. The Syva (EMIT) standards of 26, 52, 103, 155, and 258 nmol/I gave values by RIA (NML method) of 23, 49, 103, 154, and 241 nmol/l respectively.
Correlation between the EMIT-CFA method and RIA (NML method) is shown in the Figure. The correlation coefficient is O' 96, n = 40, and the slope is 0'97 with a y-axis intercept of -4 nmol/I. PRECISION Within-batch precision was measured at three levels using serum from patients. Between-batch precision was estimated using Ortho I RIA control serum (Ortho Diagnostics Ltd, High Wycombe, UK). The results, shown in Table 1 , are less satisfactory than those for assays currently run with the Cobas Bio CFA, eg, AST CV <1 % (n = 29); IgG, CV 1'4% (n = 21); IgA, CV 2'8% (n = 18); IgM, CV 7·3% (n = 21), and those quoted in the Syva method brochure for serum T4 by other EMIT instrumentation.
Precision was also investigated on duplicate assays for 43 patients' samples and for controls with T4 The Syva EMIT method for T4 gives results comparable to those found by RIA. In our hands, the Cobas Bio centrifugal analyser permits a batch of up to 20 serum thyroxine duplicate assays (including controls) to be completed in the same or less time than by conventional RIA. However, reproducibility of results using Syva EMIT reagents is less good, and we recommend the T4 EMIT to be carried out in duplicate. The method seems ideal for laboratories handling small batches or with no access to 't: counting equipment. 
